About the IPU

Pathology is a key component of patient management. Approximately 80 per cent of therapeutic decisions in a hospital every day are taken based on a pathological diagnostic opinion. In addition, pathology underpins translational and clinical research, identifying potential practical solutions to scientific discoveries. 

Pathology interrogates patient samples at all levels: ultra-structure, nucleic acid, proteins, cells, tissues and organs. In doing so, pathology takes care (through diagnostics) of the patients of today, and (through research) of the patients of tomorrow. 

Advances in microscopy, imaging and DNA sequencing are uncovering more information about tumours than ever before. Now, a high-tech specialism called digital pathology could harness this raw data in exciting new ways, making it easier and faster to diagnose cancer.

In this context, the IPU combines new and emerging tissue hybridisation technologies applied to pathology samples and workflows, with quantitated digital pathology, to achieve the following:

  • Foster research and development in the translational and clinical space
  • Lead applications of new digital pathology approaches to patient care
  • Increase the diagnostic capabilities and cultivation of artificial intelligence (AI) in digital pathology
  • Enhance the digital pathology profile within integrated diagnostics and facilitate the generation of AI targeted at improving patient care
  • By doing the above, address the need for scientific advancement in areas of significant clinical need